Is CVS Health Stock a Buy?
CVS Health (NYSE: CVS) has been a long-running migraine for shareholders, struggling to manage rising medical costs that have impacted profitability. At the time of writing, the stock is down 25% year to date and more than 40% lower than its record-high price of $101.29 set in February 2022.
The headline numbers don't project the best vital signs, but there are several reasons for investors to look up. The potential that this healthcare giant finds the right prescription to generate stronger earnings into 2025 could mark the start of a major comeback.
Let's discuss whether CVS Health stock is a buy right now.
Source Fool.com
